Q2FY25: Global Health Limited Shows Strong Financial Growth

Global Health Limited (Medanta) on Thursday announced its unaudited consolidated financial results for the quarter ending 30th September, 2024. The healthcare company posted a profit growth of 4.52 percent for the fiscal second quarter at Rs 130.82 crore in comparison to Rs 125.16 crore during the corresponding quarter of FY24. The company reported revenue from operations at Rs 956.56 crore, up 12.48 percent as against Rs 850.45 crore during the same period of the previous financial year. The company EBITDA stood at Rs 228.2 crore, up 4 percent year-on-year.

During the quarter, 52 beds were added at Lucknow and 66 beds at Patna resulting in a total bed addition of 118 beds in Q2 FY25. Average occupied bed days increased by 9.1 percent y-o-y, with strong occupancy of 64.3 percent on increased bed capacity. In-patients count increased by 8.8 percent y-o-y; Out-patients count increased by 6.6 percent y-o-y, the company stated.

Matured hospitals revenue was Rs 688.2 crore, strong growth of 13.5 percent y-o-y and 7.8 percent on q-o-q basis. EBITDA was Rs 173.9 crore, growth of 12.5 percent y-o-y and 9.4 percent on q-o-q basis. Developing hospitals revenue was Rs 2,754 million, growth of 4.2 percent y-o-y and 16.2 percent on q-o-q basis. EBITDA was Rs 823 million, down by 8.2 percent y-o-y and strong growth of 41.7 percent on q-o-q basis.

Also, International Patients Revenue was Rs 51.3 crore. The Out-patient pharmacy (Hospital + Retail) continues to register strong growth. Revenue increased by 24.5 percent from Rs 29.8 crore in Q2 FY24 to Rs 371 million in Q2 FY25.

“We are pleased to report a strong performance this quarter, achieving our highest-ever quarterly Revenue and EBITDA. Growth momentum was robust across our network hospitals, as we continue to invest in cutting-edge technologies, enhance clinical capabilities through the on-boarding of senior clinicians, and expand our network by adding more beds. I am also excited to announce that Medanta has recently signed an Operations and Management agreement to operate and manage a state-of-the-art, 750-bed super-specialty hospital in Pitampura, New Delhi,” Pankaj Sahni, Group CEO and Director said. This expansion reinforces our vision of creating a high-quality healthcare delivery platform, strengthens our presence in Delhi/NCR, and underscores our commitment to elevating patient care in the region through world-class services and infrastructure.